Which is the Best Chemotherapeutic Agent for Transarterial Chemoembolization of Hepatocellular Carcinoma?

被引：2
|
作者：
Boulin, Mathieu [1 ]
Guiu, Boris [2 ,3 ]
机构：
[1] Univ Hosp, Dept Pharm, Dijon, France
[2] St Eloi Univ Hosp, Dept Radiol, Montpellier, France
[3] St Eloi Univ Hosp, Dept Intervent Radiol, 80 Ave Augustin Fliche, F-34295 Montpellier, France
来源：
CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY | 2016年 / 39卷 / 06期
关键词：
DRUGS;
D O I：
10.1007/s00270-016-1319-0
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：953 / 954
页数：2
相关论文
共 50 条
  • [11] Warming Effect on Miriplatin–Lipiodol Suspension as a Chemotherapeutic Agent for Transarterial Chemoembolization for Hepatocellular Carcinoma: Preliminary Clinical Experience
    Shinn-ichi Kora
    Hiroshi Urakawa
    Toshimichi Mitsufuji
    Akinobu Osame
    Hideyuki Higashihara
    Kengo Yoshimitsu
    CardioVascular and Interventional Radiology, 2013, 36 : 1023 - 1029
  • [12] Erratum to: Warming Effect on Miriplatin–Lipiodol Suspension as a Chemotherapeutic Agent for Transarterial Chemoembolization for Hepatocellular Carcinoma: Preliminary Clinical Experience
    Shinn-ichi Kora
    Hiroshi Urakawa
    Toshimichi Mitsufuji
    Akinobu Osame
    Hideyuki Higashihara
    Kengo Yoshimitsu
    CardioVascular and Interventional Radiology, 2013, 36 : 1722 - 1722
  • [13] Warming Effect on Miriplatin-Lipiodol Suspension as a Chemotherapeutic Agent for Transarterial Chemoembolization for Hepatocellular Carcinoma: Preliminary Clinical Experience
    Kora, Shinn-ichi
    Urakawa, Hiroshi
    Mitsufuji, Toshimichi
    Osame, Akinobu
    Higashihara, Hideyuki
    Yoshimitsu, Kengo
    CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY, 2013, 36 (04) : 1023 - 1029
  • [14] Preoperative Transarterial Chemoembolization for Hepatocellular Carcinoma
    Kishi, Yoji
    Saiura, Akio
    Yamamoto, Junji
    Koga, Rintaro
    Seki, Makoto
    Morimura, Ryo
    Yoshioka, Ryuji
    Kokudo, Norihiro
    Yamaguchi, Toshiharu
    HEPATO-GASTROENTEROLOGY, 2012, 59 (119) : 2295 - 2299
  • [15] Which transarterial therapy is best for hepatocellular carcinoma? - The evidence to date
    Tsochatzis, Emmanuel
    Meyer, Tim
    Marelli, Laura
    Burroughs, Andrew K.
    JOURNAL OF HEPATOLOGY, 2010, 53 (03) : 588 - 588
  • [16] Preresection transarterial chemoembolization for hepatocellular carcinoma
    Sim Sai Tin
    Viroj Wiwanitkit
    Indian Journal of Gastroenterology, 2015, 34 (2) : 188 - 188
  • [17] Transarterial chemoembolization for patients with hepatocellular carcinoma
    Forner, Alejandro
    Real, M. Isabel
    Varela, Maria
    Bruix, Jordi
    HEPATOLOGY RESEARCH, 2007, 37 : S230 - S237
  • [18] Transarterial chemoembolization and sorafenib in hepatocellular carcinoma
    Cabibbo, Giuseppe
    Tremosini, Silvia
    Galati, Giovanni
    Mazza, Giancarlo
    Gadaleta-Caldarola, Gennaro
    Lombardi, Giuseppe
    Antonucci, Michela
    Sacco, Rodolfo
    EXPERT REVIEW OF ANTICANCER THERAPY, 2014, 14 (07) : 831 - 845
  • [19] Hepatocellular carcinoma under transarterial chemoembolization
    Vogl, TJ
    Trapp, ME
    Schroeder, HF
    Haupt, G
    Pegius, W
    Mack, MG
    RADIOLOGY, 1997, 205 : 65 - 65
  • [20] Preresection transarterial chemoembolization for hepatocellular carcinoma
    Tin, Sim
    Wiwanitkit, Viroj
    INDIAN JOURNAL OF GASTROENTEROLOGY, 2015, 34 (02) : 188 - 188
12345